Trial

NCT02365207

Intravesical BCG Administration to Patients With Invasive Bladder Cancer
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Condition
Bladder Cancer
Intervention
BCG strain of Mycobacterium bovis
Why stopped
Poor accrual of subjects and lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-05